Surface plasmon field-enhanced fluorescence spectroscopy (SPFS) is a promising methodology for point-of-care (POC) testing. The SPFS devices which have been reported have been equipped with an angle rotating stage to adjust the surface plasmon resonance (SPR) angle. In a clinical setting, however, the SPR angle determination is a tedious and time consuming process. In this study, we employed an SPFS instrument with a convergent optical system that allows the omission of this procedure.
Introduction
Point-of-care (POC) 1 testing allows medical personnel to carry out clinical tests at the bed side or near patients [1] . The results are immediately available, thus permitting the rapid application of clinical management decisions. Various methods such as paper chromatography [2] , electrochemical analysis [3] , surface plasmon resonance [4] [5] [6] [7] , and so on [8, 9] have been examined to develop point-of-care testing (POCT) devices. Surface plasmon field-enhanced fluorescence spectroscopy (SPFS) [10] (Scheme 1) is a promising method for the development of a highly sensitive POC device. SPFS utilizes a field-enhanced optical field of a surface plasmon mode for the excitation of fluorophores placed near the metal-dielectric interface. The evanescent field of a surface plasmon is enhanced by a factor of about 15 compared to the incident field for a gold-water interface at the specific resonance angle and then the signal decays exponentially into the dielectric medium, approximately Lz concentration in patients' blood varies within the range of 30-100 mg/mL [14, 15] , resulting in large variation of its refractive indices. Conventional SPFS devices monitor a change in fluorescence intensity at a fixed incident angle near the surface plasmon resonance (SPR)
angle, which is influenced by the refractive index near the metal-dielectric interface.
Therefore, the incident angle must be carefully adjusted to be close to the SPR angle for each patient to maximize the field intensity of the surface plasmon and thus the fluorescence intensity.
The SPFS-based devices, which have been previously reported, are equipped with an angle rotating stage to adjust the SPR angle [12, 13] . These devices should be small and consist of simple optical units for their application to POCT. In this study, we developed an SPFS-based device with a convergent optical system. Parallel incident light was focused through the lenses and a prism onto the back side of sensor chip surface, giving a fixed range of incident light angles. We examined the SPFS-based device with a convergent optical system for detecting AFP included in different concentrations of bovine serum albumin (BSA).
Materials and methods

Materials, reagents and antibodies
11-Mercaptoundecanoic acid (Sigma-Aldrich Co., St. Louis, MO, USA), SPFS-convergent) prepared in this study is schematically shown in Fig. 2(a) . A 650 nm light source of pointed LED (BL15-1212, Kodenshi corp., Kyoto, Japan) was collimated using an aspheric optical lens (No.65989, Edmond Optics Japan, Ltd, Tokyo, Japan). The light was passed through an iris (IH-08R, Sigma Koki, Tokyo, Japan) to cut the light of which the directivity was larger than 5 degrees and then linearly p-polarized with an optical filter (NT47-215, Edmond Optics Japan, Ltd, Tokyo, Japan). An S-LAL10 glass plate coated with a chromium underlayer (1 nm) and a thin gold layer (49 nm) was optically coupled to a hemi-cylinder prism via immersion oil (ref. index: 1.720, Cargille Laboratories Inc., NJ, USA). A flow cell was assembled on the glass plate by fixing a poly(methylmethacrylate) (PMMA) plate through a spacer made of silicone rubber (thickness: 1 mm), and silicone tubes (inner diameter: 0.5 mm, outer diameter: 1 mm) were connected to the space on the glass plate through the PMMA plate [13] . The sample solution or D-PBS was delivered to the glass plate through the flow cell with a peristaltic pump (SMP-21, Tokyo Rikakikai Co., Ltd., Tokyo, Japan). The p-polarized and collimated light was focused on the gold layer by an aspheric optical lens (No.48164, Edmond Optics Japan, Ltd, Tokyo, Japan).
The reflected light was captured by a CCD (ICX086AK; image sensor for NTSC color video cameras, Sony Corp., Japan) camera module (without cooling, outputting NTSC signals) and its image was recorded by a PC with recording software (VirtualDubMod ver.
1.4.13.1jp2) and analyzed by ImageJ (ver.1.4.3). The fluorescence image on the surface of the glass plate was collected through an objective lens (SLWD Plan20×, Nikon, Tokyo, Japan) and 670 nm interference filter (Optical Coatings Japan, Tokyo, Japan) with a high-sensitivity EM-CCD camera equipped with a charge multiplier (MC681-SPD; Texas Instruments, Dallas, TX, USA) cooled by a built-in peltier cooler. Acquired images were captured with an image capture board (MT-PCI2; Micro-Technica, Tokyo, Japan) and analyzed with home-made intensity scanning software. The fluorescence light intensities in selected areas (100 × 100 pixels, corresponding to 210 µm × 210 µm) were determined.
Preparation of SPFS apparatus with angle rotation stage
The SPFS instrument of Kretschmann configuration was fabricated in-house (referred to as SPFS-1spot) [13] , following the setup described by Knoll [10] , with minor modifications. Briefly, a glass plate with a thin gold layer was coupled to a triangular prism via immersion oil (Cargille). A flow cell was prepared as mentioned above. A laser diode (Coherent, Santa Clara, CA, USA) was used as a source of incident light (λ = 635 nm, 0.95 mW). The laser intensity was reduced to 10% with a neutral density (ND) filter. The laser was linearly p-polarized, then irradiated through a triangular prism at the back side of the glass plate. The incident angle was kept constant during fluorescence detection. The reflected light intensity was monitored with a photodiode detector (S2281-04; Hamamatsu Photonics, Hamamatsu, Japan). The fluorescence image on the surface of the glass plate was collected by a CCD camera (MC681-SPD) and analyzed as mentioned above.
Immobilization of antibodies on a sensor chip
Glass plates (S-LAL10, refractive index: 1.720, 25×25×1 mm) were purchased from Sigma Koki (Tokyo, Japan). They were coated with a gold layer as previously reported [13, 15] . Briefly, S-LAL10 glass plates were cleaned by plasma treatment in a plasma reactor 
Refractive index measurement of solutions
Refractive indexes of D-PBS containing 30, 70, 100 mg/mL BSA were measured using an Abbe refractometer (DR-A1, Atago Co., Ltd., Tokyo, Japan) at 25 °C. Obtained fluorescence intensities were normalized as ratios of the fluorescence intensity of the AFP solution containing 70 mg/mL BSA.
Effect of BSA concentrations on SPFS-based immunoassay for detection of AFP
Quantitative determination of AFP concentrations in fetal bovine serum
A series of AFP solutions (0-20 ng/mL) in FBS were prepared just before each measurement. An aqueous solution containing 35 mg/mL NaCl, whose refractive index is 1.339, was applied onto a sensor chip to adjust the incident angle to the SPR angle. An ahAFP-A647 solution was added to 2 ml of AFP solution at a final concentration of 10 nM and incubated for 10 min to form the antigen-antibody complex at room temperature. The antigen-antibody complex in FBS was applied to a flow cell of the SPFS apparatus.
Fluorescence intensity was recorded. New sensor chips were used in each measurement in a series of AFP solutions in FBS.
Statistical analyses and detection limit
Data from the experiments were expressed as the mean ± standard deviation (SD).
Detection limit was determined from the 3.3 SD of baseline measurements (FBS without AFP). All calculation and statistical analysis were executed on R language environment ver.
2.12.0 [17] .
Results
Effects of protein concentration on the intensities of fluorescent light as detected by two SPFS devices with different optical units
Protein concentration in blood samples varies in patients from about 30 to 100 mg/mL [14, 15] . Variations in refractive index due to changes in protein concentration would [18] . Fig. 1(a) shows dependences of reflectance and enhancement factors on light incident angles for the 30, 70, 100 mg/mL BSA solutions. SPR angles, minimums of reflectance, and light incident angles which give maximums of enhancement factors are summarized in Table 1 . The SPR angle and the light incident angle for maxima of enhancement factors increased with the increase of BSA concentrations. Although there are small differences between the SPR angle and the angles which give the maximum of the field enhancement factor ( Fig. 1(a) ), this difference was ignored for SPFS in the following arguments. Fig. 2(a) shows the alignment of optical units. A parallel incident light beam was focused on the back side of the sensor of the SPFS apparatus.
SPFS with convergent light beam:
Incident angle range was set to be an angle that gave the maximum enhancement factor Fluorescent light intensities estimated for SPFS devices with different optical systems are also summarized in Table 1 for ease of comparison. These calculations indicated that the SPFS apparatus with convergent optical system efficiently suppressed the dependency of the fluorescence intensity on the protein concentrations in the serum in patients and thus is suitable for POC.
SPFS apparatus with convergent optical system
Our SPFS apparatus with the convergent optical system was composed of an light source, alignment of optical units, SPR measurement and SPFS measurement units as schematically shown in Fig. 2(a) . A photograph of its prototype is shown in Fig. 3(a) . Light from a pointed LED was passed through an iris, collimated, p-polarized, and then focused on the back side of a sensor, giving a fixed range (center ± 5º) of incident angle. Reflected light was captured by a CCD camera for SPR measurement and the fluorescence image on the sensor surface was observed by a highly sensitive CCD camera for SPFS measurement.
An image of the reflected light is shown in Fig. 3 Averaged whole area fluorescent intensity was employed hereafter.
Quantitative measurement of AFP in fetal bovine serum
The efficacy of our SPFS system for detection of low levels of AFP in serum was evaluated by using solutions of AFP in FBS. Anti-human AFP 6D2 antibody labeled with Alexa-Fluor 647 was mixed with AFP solution in FBS and incubated at room temperature for 10 min to form an AFP antibody-Alexa-Fluor 647 complex. The solution was applied to a sensor surface on which primary anti-AFP antibody was immobilized. The intensities of fluorescent light were integrated for 26 small areas (Fig. 3(c-1) ) before and after the AFP antibody-Alexa-Fluor 647 complexes were applied. Fluorescent light intensity caused by the complex on the sensor surface was estimated by the difference between the integrated light intensity before and after the complex was applied. As shown Fig. 4(a Fig. 4(b) ). Linear regression analysis of these plots (Fig. 4(b) ) indicated a strong linear relationship (R 2 = 0.995). The standard derivation of the elevation in the rates of fluorescence intensity obtained from FBS without AFP was 338 a.u./min (n=12). Therefore the limit of detection of our prototype SPFS-convergent apparatus was estimated to be 0.68 ng/mL for AFP.
Effect of protein concentration on fluorescence intensity
As shown in Table 1 
Discussion
We assessed the efficacy of our SPFS apparatus with a convergent optical system as a POC device with high sensitivity. Immunoassay of AFP using our SPFS apparatus demonstrated that the fluorescent intensity increased linearly due to binding of AFP-antibody-Alexa-Fluor 647 complex to a sensor surface and the slope was in proportion to the AFP concentrations (Fig. 4(b) ). Our SPFS-based immunoassay could determine the AFP concentration within 20 min after we received the plasma sample. The limit of detection for AFP in FBS was determined to be 0.68 ng/mL. There are several sensitive assay methods used in clinical diagnosis, such as enzyme-linked immunosorbent assays (ELISA), chemiluminescence immune assay (CLIA), and radioimmunoassay (RIA). The detection limit of AFP is about 2 ng/mL for commercially available ELISA [19] , 0.5 ng/mL for ECLIA [20] , and RIA [21] . Approximately 97% of the healthy subjects have AFP levels less than 8.5 ng/mL [22] . We therefore concluded that our prototype SPFS apparatus is sensitive enough for clinical diagnosis of AFP concentrations and gives clinical test results within the permissive range of time for measurements at the bed-side. ELISA, CLIA, and RIA, all of which are clinically used, require more than 10 steps including washing samples to remove unbound complexes. In contrast, our SPFS-based immunoassay could determine AFP concentration in samples without removal of unbound complexes (Fig. 4) . This result makes this SPFS apparatus suitable for POC testing, eliminating the time consuming and tedious procedures and allowing immediate clinical management decisions to be made.
The application of this SPFS apparatus to clinical diagnosis will benefit from some improvements. The SPFS apparatus utilizes the enhanced evanescent field caused by the SPR phenomenon of excitation of a fluorescent dye. As shown in Fig. 1 , the light incident angle, at which the evanescent field gives its maximum response, depends on the refractive index near the metal surface. Therefore, fluorescence intensity changed in a manner dependent on the protein concentration of the sample, even though the concentration of the antigen AFP remained the same. We developed the SPFS apparatus with the convergent optical system to solve this problem and expected that the incident light angle would equal the SPR angle + 5°.
Theoretical calculation using Fresnel's equation and experiments demonstrated less variation in the changes in fluorescence intensity caused by differences in protein concentration.
Although the SPFS-convergent apparatus greatly suppressed the effect of BSA concentration on the relative increases in the rates of fluorescence increase (Fig. 5) , these dependences were larger than those calculated using Fresnel's equation. We suspect non-uniformity of the incident light might be the cause of the difference between the experimental and calculated values. Ideally, the intensity of the incident light should be the same at any incident angle. A LED was used as a light source in our SPFS apparatus and the emitted light whose directivity was larger than 10° was cut by an iris to obtained uniform light flux. As seen in the SPFS image shown in Fig. 3(c-1) , however, its central section was brighter than its periphery.
Thus, the illumination assembly needs to be improved to reduce the size of illuminated area.
Additionally, the use of a photomultiplier instead of CCD camera might improve readability of signal by permitting the collection all fluorescence light emitted from the sample.
Many bright spots were observed in SPFS image of the sensor surface as shown in Fig. 3(c-1) . Their size was larger than 10 µm in diameter. When a gold surface was observed by an optical microscope and an atomic force microscope, such large granules were not found.
These bright spots might be caused by coupling of surface plasmon-polaritons due to the roughness of the granules of gold on a sensor chip, as pointed out by Rothenhaesler [23] . If number and location of these spots could be well controlled, fluorescent intensities would be greater enhanced due to the effect of localized plasmon-polaritons. These bright spots, however, caused heterogeneity of the sensor-chip surface, making difficult the direct correlation between fluorescent intensity and antigen AFP concentration.
Conclusions
We fabricated an SPFS apparatus using a convergent optical system, giving a fixed 
